Role of p16/Ki-67 Dual immunostaining in detection of cervical cancer precursors
Open Access
- 1 January 2018
- journal article
- research article
- Published by Medknow in Journal of Cytology
- Vol. 35 (3), 153-158
- https://doi.org/10.4103/joc.joc_4_17
Abstract
Background: Pap-smears-based cytology and human papilloma virus testing have their own limitations in detecting cervical precancerous lesions, and still need further standardization. Co-expression of p16ink4a and Ki-67 can be used as additional biomarker. Aims: To study the role of liquid-based cytology and the dual immunostaining for p16/Ki-67 in predicting the presence of significant lesion in cases of mild cytological atypia. Materials and Methods: A prospective, cross-sectional study was performed in the Department of Pathology, in collaboration with Department of Obstetrics and Gynecology over 15 months including 545 patients. Immunocytochemistry followed by colposcopy-guided biopsy were performed in 52 cases with epithelial abnormalities. Results: Thirty-five cases (67%) were dual-stain positive among the cases with epithelial abnormalities. In the ASC-US and LSIL group, the sensitivity and specificity of the immunostaining in diagnosing CIN2+ lesions were 100 and 70% and 87.5 and 100%, respectively. p16/Ki-67 positivity also increased with cytological severity which in turn corresponded with histological findings: it reached from 33% in ASC-US to 100% in both HSIL and SCC categories. Conclusion: This dual immunostaining may potentially be a useful tool in the triage of the ASC-US and the LSIL group, considering the high sensitivity and specificity values.Keywords
This publication has 17 references indexed in Scilit:
- p16/Ki-67 dual staining in cervico-vaginal cytology: Correlation with histology, Human Papillomavirus detection and genotyping in women undergoing colposcopyGynecologic Oncology, 2012
- Performance of p16/Ki-67 Immunostaining to Detect Cervical Cancer Precursors in a Colposcopy Referral PopulationClinical Cancer Research, 2012
- CINtec® PLUS dual immunostain: A triage tool for cervical pap smears with atypical squamous cells of undetermined significance and low grade squamous intraepithelial lesionDiagnostic Cytopathology, 2012
- Evaluation of CINtec PLUS® testing as an adjunctive test in ASC‐US diagnosed SurePath® preparationsDiagnostic Cytopathology, 2011
- Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytologyGynecologic Oncology, 2011
- p16/ki‐67 dual‐stain cytology in the triage of ASCUS and LSIL Papanicolaou cytologyCancer Cytopathology, 2011
- High-Risk Human Papillomavirus Testing in Women With ASC-US CytologyAmerican Journal of Clinical Pathology, 2011
- HPV vaccination and colposcopy workload of screening programmesVaccine, 2008
- Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing CountriesVaccine, 2008
- Predicting absolute risk of CIN3 during post-colposcopic follow-up: Results from the ASCUS-LSIL Triage Study (ALTS)American Journal of Obstetrics and Gynecology, 2006